Announcement PDF Page | 1 ME_963695403_2 Notice of Extraordinary General Meeting Friday, 26 June 2026 10.00am AEST Level 2, 1 Taubman Street, Symonston, ACT 2609 Electro Optic Systems Holdings Limited ACN 092 708 364 Page | 2 Participation in the EGM This Extraordinary General Meeting (EGM) of Electro Optic Systems Holdings Limited (EOS or Company) will be held on Friday, 26 June 2026 commencing at 10.00am (AEST) at Level 2, 1 Taubman Street, Symonston, ACT 2609. Shareholders can participate in the EGM in the following ways: Before the EGM EGM Notice of Meeting Vote or appoint proxy Ask a question Access online at https://eos-aus.com/investor/ Return the hard copy Voting Form or vote online at https://au.investorcentre.mpms.mu fg.com To be valid, your Direct Vote or proxy appointment must be received by 10.00am AEST on Wednesday, 24 June, 2026 Submit questions online at https://au.investorcentre.mpms. mufg.com by 5.00pm on Monday, 22 June 2026 Request a hard copy of the Notice of Meeting by phone at +61 1300 554 474 or email communications@cm.mpms.mufg.com At the EGM Attend the EGM in person The EGM will be held at Level 2, 1 Taubman Street, Symonston, ACT 2609. Shareholders, proxyholders, body corporate representatives or attorneys attending the meeting in person will be able to ask questions or make a comment and vote at the meeting. If you would like to receive a printed copy of this Notice of Meeting or any future notices, please contact the Share Registry on + 61 1300 554 474. Page | 3 Notice of Extraordinary General Meeting Notice is hereby given that an Extraordinary General Meeting (EGM) of Shareholders of Electro Optic Systems Holdings Limited (Company or EOS) will be held on Friday,, 26 June 2026 at 10.00am (AEST) at Level 2, 1 Taubman Street, Symonston, ACT 2609 (Meeting). The Explanatory Memorandum accompanying this Notice provides additional information on matters to be considered at the Meeting. The Explanatory Memorandum, Voting Procedures and the Voting Form comprise part of this Notice. Items of business __________________________________________________________________________________ Item 1: Approval to issue Strategic Placement Shares to Generation 5 Holding L.L.C To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: 'That the issue of 3,750,000 Strategic Placement Shares at A$8.00 per Share to Generation 5 Holding L.L.C under the Strategic Placement is approved under and for the purposes of Listing Rule 7.1 and for all other purposes, on the terms and conditions in the Explanatory Memorandum'. Note: A voting exclusion applies to this resolution (see Explanatory Memorandum for details). Item 2: Approval to issue Strategic Placement Shares to Strategic Placement Participant To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: 'That the issue of 1,250,000 Strategic Placement Shares at A$8.00 per Share to the Strategic Placement Participant (or their respective nominee(s)) under the Strategic Placement is approved under and for the purposes of Listing Rule 7.1 and for all other purposes, on the terms and conditions in the Explanatory Memorandum'. Note: A voting exclusion applies to this resolution (see Explanatory Memorandum for details). Item 3: Ratification of prior issue of performance rights in connection with acquisition of MARSS To consider, and if thought fit, pass the following as an ordinary resolution of the Company: 'That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify and confirm the issue of 21 Performance Rights (which on vesting will result in the issuance of up to 28,942,814 Shares) in connection with the Company's acquisition of MARSS, on the terms and conditions set out in the Explanatory Memorandum.' Note: A voting exclusion applies to this resolution (see Explanatory Memorandum for details). Page | 4 Voting Procedures All resolutions will be by poll _________________________________________________________________________ In accordance with clause 40.2 of the Company’s Constitution (Constitution) the Chair intends to demand a poll on each of the resolutions proposed at the Meeting. Each resolution considered at the Meeting will therefore be conducted by a poll. The Chair considers voting by poll to be in the interests of Shareholders as a whole and is a way to ensure the views of as many Shareholders as possible are represented at the Meeting. Entitlement to vote _________________________________________________________________________ The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders of the Company as at 7.00pm (AEST) on Wednesday, 24 June 2026 (Entitlement Time). This means that if you are not the registered holder of a Share in the Company at the Entitlement Time, you will not be entitled to vote at the Meeting. How to vote – before the EGM _________________________________________________________________________ Direct vote – using the Voting Form In accordance with clause 50 of the Constitution, Shareholders are able to vote directly on resolutions considered at the Meeting at any time between the date of this Notice of Meeting and 10.00am (AEST) on 10.00am, Wednesday, 24 June 2026 by returning the hard copy Voting Form or by voting online (further details below). If you lodge a direct vote you are voting directly and are not appointing a third party, such as a proxy, to act on your behalf. The EOS Direct Voting Regulations governing direct voting are available on the Company website at https://eos- aus.com/about-us/corporate-governance/. By submitting a direct vote, you agree to be bound by the EOS Direct Voting Regulations. Appointment of Proxy A Shareholder who is entitled to vote at the Meeting is entitled to appoint not more than two proxies to vote in place of the Shareholder. If the Shareholder appoints two proxies, the Shareholder may specify the proportion or number of votes each proxy is entitled to exercise. If no proportion or number of votes is specified, each proxy may exercise half of the Shareholder’s votes. If the specified proportion or number of votes exceeds that which the Shareholder is entitled to, each proxy may exercise half of the Shareholder’s votes. Any fractions of votes brought about by the apportionment of votes to a proxy will be disregarded. A proxy need not be a Shareholder of the Company. A body corporate appointed as a Shareholder’s proxy may appoint a representative to exercise any of the powers the body may exercise as a proxy at the Meeting. The representative should bring to the Meeting evidence of his or her appointment, including any authority under which the appointment is signed, unless it has previously been given to the Company. If a Shareholder: - has not directed their proxy how to vote on Items the subject of this Meeting, the proxy may vote as the proxy determines; and - appoints the Chair of the Meeting as proxy and does not direct the Chair how to vote on an Item of business, the Chair will vote in accordance with his voting intention as stated in this Notice of Meeting. Page | 5 Submitting your Voting Form To be valid, a Voting Form must be received by the Company in the manner set out in this Notice. The Chair’s decision on the validity of a direct vote, vote cast by a proxy or vote cast in person, is conclusive and the Company reserves the right to declare invalid any Voting From not received in this manner. For your proxy or direct vote prior to the EGM to be effective, your completed, signed and lodged Voting Form (together with the relevant original power of attorney or a certified copy of the proxy signed by an attorney) must be received by the Company’s Share Registry, MUFG Corporate Markets (AU) Limited , no later than 10.00am (AEST) on Wednesday, 24 June 2026 (Proxy Deadline). After this time, you will still be able to lodge your vote during the EGM by attending the Meeting in person. Voting forms may be submitted in one of the following ways: Online: Via the Company’s Share Registry at https://au.investorcentre.mpms.mufg.com. You will need your control number (see proxy form), Securityholder Reference Number (SRN) or Holding Identification Number (HIN) and postcode for your shareholding. Mobile device: Using a mobile device by scanning the QR code on the front of the Voting Form. You will also need your postcode for your shareholding. By post: MUFG Corporate Markets (AU) Limited Locked Bag A14, Sydney South NSW 1235 Australia. Please allow sufficient time so that it reaches MUFG by the Proxy Deadline. By fax: +61 2 9287 0309 By hand delivery: MUFG Corporate Markets (AU) Limited, Parramatta Square, Level 22, Tower 6, 10 Darcy Street, Parramatta NSW 2150. Voting Forms and Powers of Attorney must be received by the Proxy Deadline. Power of Attorney A proxy appointment and the original power of attorney (if any) under which the proxy appointment is signed (or a certified copy of that power of attorney or other authority) must be received by the Company no later than the Proxy Deadline. Corporate Representatives A body corporate which is a Shareholder, or which has been appointed as a proxy, is entitled to appoint any person to act as its representative at the Meeting. The appointment of the representative must comply with the requirements under section 250D of the Corporations Act. The representative must bring to the EGM a properly executed letter or other document confirming its authority to act as the body corporate’s representative. A ‘Certificate of Appointment of a Corporate Representative’ form can be obtained from the Share Registry or online at https://au.investorcentre.mpms.mufg.com by selecting "Printable Forms". How to vote – during the EGM _________________________________________________________________________ Attending in person Shareholders, proxyholders, body corporate representatives or attorneys attending the Meeting in person will be able to vote and ask questions or make comments, at the Meeting. Proxy Voting by the Chair _________________________________________________________________________ The Chair intends to vote all undirected proxies in favour of all resolutions in the Notice convening the Meeting. Questions and Comments from Shareholders _________________________________________________________________________ Before the EGM Page | 6 Shareholders can submit questions in advance of the EGM via the Share Registry website at https://au.investorcentre.mpms.mufg.com. To allow time to collate questions and prepare answers, please submit any questions by 5.00pm on Monday, 22 June 2026. Questions will be collated and the Chair and/or CEO will seek to address as many of the more frequently raised topics as possible during the EGM. Please note that individual responses will not be sent to Shareholders. During the EGM Shareholders, proxyholders, body corporate representatives or attorneys attending the Meeting in person will be able to ask questions or make comments during the Meeting. BY ORDER OF THE BOARD Melanie Andrews BComm, FCPA, MBA, GAICD Company Secretary 27 May 2026 Page | 7 Explanatory Memorandum This Explanatory Memorandum has been prepared for the information of Shareholders of the Company in relation to the business to be conducted at the Company’s EGM to be held at 10.00am AEST on Friday, 26 June 2026. This Explanatory Memorandum provides Shareholders with information that is reasonably required for them to decide how to vote on the resolutions. The Board recommends that Shareholders vote in favour of all resolutions. The Chair intends to vote all undirected proxies in favour of all resolutions in the Notice convening the Meeting. The resolutions in this Notice of Meeting ordinary resolutions, which require a simple majority of votes cast by Shareholders entitled to vote on the resolution. _________________________________________________________________________ Item 1: Approval to issue Strategic Placement Shares to Generation 5 Holding L.L.C Background On 20 May 2026, the Company announced the completion of a fully underwritten institutional placement to raise approximately A$150 million (before costs) (Institutional Placement) through the issue of 18,750,000 new Shares to institutional investors at an issue price of A$8.00 per Share pursuant to the Company's existing Listing Rule 7.1A capacity (Institutional Placement Shares). The Institutional Placement Shares were issued on 25 May 2026. Also, on 20 May 2026, the Company also announced a non-underwritten strategic placement to raise A$40 million (before costs) in addition to the Institutional Placement and conditional on shareholder approval under Listing Rule 7.1 (Strategic Placement) through the issue of 5,000,000 new Shares to Generation 5 Holding L.L.C. (a related entity of Calidus L.L.C, a major provider of defence equipment, technology and services based in Abu Dhabi) (Generation 5) and another institutional investor focussed on the defence sector (Strategic Placement Participant) at A$8.00 per Share (Strategic Placement Shares) as follows: • 3,750,000 Strategic Placement Shares to Generation 5 to raise A$30 million; and • 1,250,000 Strategic Placement Shares to the Strategic Placement Participant to raise A$10 million, (together with the Institutional Placement, the Placement). For further details of the Placement, please refer to the Company's announcements dated 18 May 2026 and 20 May 2026. Proceeds from the Placement and the Company's proposed share purchase plan (SPP), together with the secured term loan facility provided by Washington H. Soul Pattinson (as previously announced on 12 January 2026), will be used to fund the upfront consideration of the MARSS acquisition, and increase balance sheet flexibility to pursue growth opportunities and execute on strategic initiatives. General Resolution 1 seeks the approval of Shareholders for the issue of 3,750,000 Strategic Placement Shares to Generation 5 under and for the purposes of Listing Rule 7.1. Listing Rule 7.1 Listing Rule 7.1 provides that a listed company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12-month period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12-month period. As the issue of the Strategic Placement Shares to Generation 5 does not fit within any of the exceptions to Listing Rule 7.1 (and exceeds the 15% limit in Listing Rule 7.1), approval from the Company's Shareholders is required to be obtained for the issue of the Strategic Placement Shares to Generation 5. To this end, Resolution 1 seeks the required Shareholder approval to the issue of 3,750,000 Strategic Placement Shares to Generation 5 under and for the purposes of Listing Rule 7.1. If Resolution 1 is passed, the Company will be able to proceed with the issue and raise $30 million for the purposes outlined in the 'Background' above. In addition, the issue will be excluded from the calculation of the number of Equity Securities that the Company can issue without Shareholder approval under Listing Rule 7.1. Page | 8 If Resolution 1 is not passed, the Company will not be able to proceed with the issue of the Strategic Placement Shares to Generation 5. Specific information required by Listing Rule 7.3 Under and for the purposes of Listing Rule 7.3, the following information is provided in relation to the proposed issue of the Strategic Placement Shares to Generation 5: (a) the Strategic Placement Shares will be issued to Generation 5; (b) a maximum of 3,750,000 Strategic Placement Shares are to be issued under this Resolution 1; (c) the issue of the Strategic Placement Shares to Generation 5 will be issued as fully paid ordinary shares in the capital of the Company and will rank equally in all respects with the Company's existing Shares on issue; (d) the Strategic Placement Shares will be issued to Generation 5 no later than three months after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules), and it is intended they be issued on or around 1 July 2026; (e) the Strategic Placement Shares will be issued to Generation 5 at A$8.00 per Share; (f) the proceeds from the issue of the Strategic Placement Shares to Generation 5 will be used for the same purposes as all other funds raised under the Placement (as set out under the heading 'Background' above); (g) there are no additional material terms with respect to the subscription agreement for the issue of the Strategic Placement Shares to Generation 5 other than that settlement of the issue will not proceed unless the Company obtains Shareholder approval for the issue of the Strategic Placement Shares to Generation 5 under Listing Rule 7.1, by 15 July 2026 (or such other date as the parties agree). Voting Exclusion The Company will disregard any votes cast on the resolution in Item 1 by Generation 5 and any Associates of that person or those persons. However, this does not apply to a vote cast in favour of this resolution by: (a) a person as proxy or attorney for a person who is entitled to vote on Item 1, in accordance with the directions given to the proxy or attorney to vote on these resolutions in that way; or (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Item 1, in accordance with a direction given to the Chair to vote on these resolutions as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting on Item 1; and (ii) the holder votes on Item 1 in accordance with directions given by the beneficiary to the holder to vote in that way. Board recommendation The Board recommends that Shareholders vote in favour of Resolution 1. Item 2: Approval to issue Strategic Placement Shares to the Strategic Placement Participant General Details of the Strategic Placement are outlined above in the 'Background' to Item 1. Resolution 2 seeks the approval of Shareholders for the issue of 1,250,000 Strategic Placement Shares to the Strategic Placement Participant (or its nominee) under and for the purposes of Listing Rule 7.1. Listing Rule 7.1 A summary of Listing Rule 7.1 is contained in Item 1 above. Page | 9 The proposed issue of Strategic Placement Shares does not fall within any of these exceptions and exceeds the 15% limit in Listing Rule 7.1. It therefore requires the approval of Shareholders under Listing Rule 7.1. To this end, Resolution 2 seeks the required Shareholder approval to the issue of 1,250,000 Strategic Placement Shares to the Strategic Placement Participant (or its nominee) under and for the purposes of Listing Rule 7.1. If Resolution 2 is passed, the Company will be able to proceed with the issue and raise A$10 million for the purposes outlined in Item 1 under the heading 'Background'. In addition, the issue will be excluded from the calculation of the number of Equity Securities that the Company can issue without Shareholder approval under Listing Rule 7.1. If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the Strategic Placement Shares to the Strategic Placement Participant. Specific information required by Listing Rule 7.3 Under and for the purposes of Listing Rule 7.3, the following information is provided in relation to the proposed issue of the Strategic Placement Shares to the Strategic Placement Participant: (a) the Strategic Placement Shares will be issued to the Strategic Placement Participant (being an institutional investor focussed on the defence sector); (b) a maximum of 1,250,000 Strategic Placement Shares are to be issued under this Resolution 2; (c) the issue of the Strategic Placement Shares to the Strategic Placement Participant will be issued as fully paid ordinary shares in the capital of the Company and will rank equally in all respects with the Company's existing Shares on issue; (d) the Strategic Placement Shares will be issued to the Strategic Placement Participant no later than three months after the date of the Meeting (or such later date as permitted by any ASX waiver or modification of the Listing Rules), and it is intended they be issued on or about 1 July 2026; (e) the Strategic Placement Shares will be issued to the Strategic Placement Participant at A$8.00 per Share; (f) the proceeds from the issue of the Strategic Placement Shares to the Strategic Placement Participant will be used for the same purposes as all other funds raised under the Placement (as set out under the heading 'Background' in Item 1 above); (g) there are no additional material terms with respect to the subscription agreement for the issue of the Strategic Placement Shares to the Strategic Placement Participant other than that settlement of the issue will not proceed unless the Company obtains Shareholder approval for the issue of the Strategic Placement Shares to the Strategic Placement Participant under Listing Rule 7.1, by 15 July 2026 (or such other date as the parties agree). Voting Exclusion The Company will disregard any votes cast on the resolution in Item 2 by the Strategic Placement Participant and any Associates of that person or those persons. However, this does not apply to a vote cast in favour of this resolution by: (a) a person as proxy or attorney for a person who is entitled to vote on Item 2, in accordance with the directions given to the proxy or attorney to vote on these resolutions in that way; or (b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on Item 2, in accordance with a direction given to the Chair to vote on these resolutions as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting on Item 2; and (ii) the holder votes on Item 2 in accordance with directions given by the beneficiary to the holder to vote in that way. Board recommendation Page | 10 The Board recommends that Shareholders vote in favour of Resolution 2. Item 3: Ratification of prior issue of Performance Rights in connection with acquisition of MARSS Background As announced to ASX on 12 January 2026, the Company has entered into a binding agreement to acquire the MARSS group business (MARSS) and, as announced to ASX on 15 May 2026, the Company agreed to certain amendments to the binding agreement (as amended, the MARSS Agreement) and the acquisition of MARSS was completed on 21 May 2026. MARSS is a defence and security technology provider focused on developing and marketing sensor-fusion technology and AI-enabled C2 systems primarily for counter-drone use. The acquisition includes MARSS’ NiDAR C2 technology, sensor-fusion and AI software platform and hardware offering, along with associated customer contracts, intellectual property and personnel. Under the terms of the MARSS Agreement, the Company agreed to pay the following consideration to acquire the MARSS business: • upfront cash payment of €36m payable to the MARSS vendors; plus • additional contingent consideration of up to €140m in value payable to management shareholders of MARSS via a three tranche earnout (Earnout) which was facilitated by way of the issue of 21 performance rights (MARSS Performance Rights) to such MARSS management shareholders on completion of the MARSS acquisition, which occurred on 21 May 2026. If the Earnout is achieved, the Performance Rights will vest into a maximum of 28,942,814 Shares at a price of: o in respect of the first 23,529 411 Shares, A$7.40 per Share; and o in respect of the next 5,413,403 Shares, at a conversion price equal to the volume weighed average of the Share price in the 5 trading days (converted into euros at the exchange rate on the day) prior to completion of the acquisition of MARSS (“New Conversion Price”). If the aggregate amount payable under the MARSS Performance Rights exceeds the value of those 28,942,814 Shares at those prices, the balance will be payable in cash. Further details of the Earnout and the MARSS acquisition (including the amendments agreed to by the Company on 15 May 2026) are set out in the Company's announcements to ASX. The announcement dated 12 January 2026 and titled 'Acquisition of MARSS Counter-Drone C2 System Provider' provides details of the MARSS business, and the announcement dated 15 May 2026 and titled 'Capital Raising to Support Growth Opportunities' provides details of the amendments to the MARSS Agreement. ASX Listing Rule 7.4 ASX Listing Rule 7.1 restricts the number of Equity Securities which a listed entity may issue in any 12 month period, without the approval of Shareholders, to 15% of the number of securities on issue at the start of the period, subject to certain adjustments and permitted exceptions. The issue of the MARSS Performance Rights under the MARSS Agreement does not fit within any of the exceptions in the ASX Listing Rule 7.2 and, as it has not yet been approved by the Shareholders, it uses all of the Company's 15% placement capacity under ASX Listing Rule 7.1. This reduces the Company’s capacity to issue further Equity Securities without Shareholder approval under ASX Listing Rule 7.1 for the 12 month period following the date of the agreements to issue of the MARSS Performance Rights. ASX Listing Rule 7.4 provides that an issue of securities is deemed to have been made with Shareholder approval if ASX Listing Rule 7.1 is not breached at the time the securities were issued and Shareholders subsequently approve the issue of Equity Securities. If Shareholders ratify the issue of the MARSS Performance Rights pursuant to the resolution in Item 3 the issue of the MARSS Performance Rights (and the 28,942,814 Shares into which they vest) is taken to have been approved under ASX Listing Rule 7.1 and the issue of the MARSS Performance Rights and the Shares into which they vest will not reduce the Company's capacity to issue further Equity Securities under ASX Listing Rule 7.1 over the following 12 month period. To this end, the resolution in Item 3 seeks Shareholder ratification for the issue by the Company of the MARSS Performance Rights (and the 28,942,814 Shares into which they may vest) under the MARSS Agreement, and for the purposes of ASX Listing Rule 7.4. If Shareholders approve the resolution in Item 3, the issue of the MARSS Performance Rights (and the 28,942,814 Shares into which they may vest) will be excluded in calculating the Company's 15% placement capacity in ASX Listing Rule 7.1. This Page | 11 increases the number of Equity Securities the Company can issue without Shareholder approval over the 12 month period following the dates of the agreements to issue of the MARSS Performance Rights. If Shareholder approval is not obtained If Shareholders do not approve the resolution in Item 3, the issue of the MARSS Performance Rights (and the 28,942,814 Shares into which they vest) will remain as issued under the Company’s 15% placement capacity in ASX Listing Rule 7.1 for a period of 12 months following their dates of agreements to issue. This decreases the number of Equity Securities the Company can issue without Shareholder approval over the 12 month period following the dates of agreements of issue of the MARSS Performance Rights. Information required by ASX Listing Rule 7.5 The following information is provided to Shareholders to allow them to assess the resolution in Item 3, including for the purposes of ASX Listing Rule 7.5: i. Names of the persons to whom the MARSS Performance Rights are to be issued or the basis on which those persons were identified or selected The MARSS Performance Rights the subject of this resolution were issued to those sellers of the MARSS assets who are management shareholders of MARSS (MARSS Management Shareholders). No MARSS Management Shareholder is a related party of the Company, a member of KMP, a substantial shareholder of the Company, an adviser to the Company or an Associate of any such party. ii The number and class of securities to be issued Shareholders are being asked to approve the issue of an aggregate of 21 Performance Rights to seven MARSS Management Shareholders comprising 1 A1 Class Performance Right, 1 A2 Class Performance Right, 1 A3 Class Performance Right, 1 B1 Class Performance Right, 1 B2 Class Performance Right, 1 B3 Class Performance Right, 1 C1 Class Performance Right, 1 C2 Class Performance Right, 1 C3 Class Performance Right, 1 D1 Class Performance Right, 1 D2 Class Performance Right, 1 D3 Class Performance Right, 1 E1 Class Performance Right, 1 E2 Class Performance Right, 1 E3 Class Performance Right, 1 F1 Class Performance Right, 1 F2 Class Performance Right, 1 F3 Class Performance Right, 1 G1 Class Performance Right, 1 G2 Class Performance Right and 1 G3 Class Performance Right. The MARSS Performance Rights will vest, if the Earnout is achieved, into a maximum of 28,942,814 Shares. iii If the securities are not fully paid ordinary securities, a summary of the material terms of the securities The table below summaries the key terms of the MARSS Performance Rights: Term Details Number of MARSS Performance Rights The MARSS Management Shareholders were issued the following performance rights on 22 May 2026: ▪ MARSS Management Shareholder #1: 1 A1 Class Performanc